Perforin Is Detrimental to Controllinγ C. muridarum Replication In Vitro, but Not In Vivo

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Johnson, Raymond M ^a   Kerr, Micah S ^a   Slaven, James E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; CD4+ T LYMPHOCYTE; CELL INTERACTION; CELL POLARITY; CHLAMYDIA; CONTROLLED STUDY; CYTOLYSIS; EPITHELIUM CELL; FEMALE; GENITAL TRACT INFECTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CHLAMYDIA MURIDARUM; EPITHELIAL CELLS; FEMALE; GENE KNOCKOUT TECHNIQUES; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; PERFORIN; REPRODUCTIVE TRACT INFECTIONS;

EID: 84877764745     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063340     Document Type: Article

References (34)

1. (2011) Sexually Transmitted Disease Surveillance 2010. In: Prevention CfDCa, editor. Atlanta, GA: U.S. Department of Health and Human Services.
2. Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML, (2005) The Unexpected Impact of a Chlamydia trachomatis Infection Control Program on Susceptibility to Reinfection. J Infect Dis 192: 1836-1844.
3. Brunham RC, Rekart ML, (2008) The arrested immunity hypothesis and the epidemiology of chlamydia control. Sex Transm Dis 35: 53-54.
4. Rekart ML, Brunham RC, (2008) Epidemiology of chlamydial infection: are we losing ground? Sex Transm Infect 84: 87-91.
5. Schachter J, (1985) Overview of Chlamydia trachomatis infection and the requirements for a vaccine. Rev Infect Dis 7: 713-716.
6. Morrison RP, Caldwell HD, (2002) Immunity to murine chlamydial genital infection. Infect Immun 70: 2741-2751.
7. Igietseme JU, He Q, Joseph K, Eko FO, Lyn D, et al. (2009) Role of T lymphocytes in the pathogenesis of Chlamydia disease. J Infect Dis 200: 926-934.
8. Murthy AK, Li W, Chaganty BK, Kamalakaran S, Guentzel MN, et al. (2011) Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect Immun 79: 2928-2935.
9. Igietseme JU, (1996) The molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide. Immunology 87: 1-8.
10. Igietseme JU, Uriri IM, Hawkins R, Rank RG, (1996) Integrin-mediated epithelial-T cell interaction enhances nitric oxide production and increased intracellular inhibition of Chlamydia. J Leukoc Biol 59: 656-662.
11. Igietseme JU, Perry LL, Ananaba GA, Uriri IM, Ojior OO, et al. (1998) Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect Immun 66: 1282-1286.
12. Ramsey KH, Miranpuri GS, Poulsen CE, Marthakis NB, Braune LM, et al. (1998) Inducible nitric oxide synthase does not affect resolution of murine chlamydial genital tract infections or eradication of chlamydiae in primary murine cell culture. Infect Immun 66: 835-838.
13. Johnson RM, Kerr MS, Slaven JE, (2012) Plac8-dependent and inducible NO synthase-dependent mechanisms clear Chlamydia muridarum infections from the genital tract. J Immunol 188: 1896-1904.
14. Ramsey KH, Miranpuri GS, Sigar IM, Ouellette S, Byrne GI, (2001) Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome. Infect Immun 69: 5131-5137.
15. Perry LL, Feilzer K, Hughes S, Caldwell HD, (1999) Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis. Infect Immun 67: 1379-1385.
16. Jayarapu K, Kerr M, Ofner S, Johnson RM, (2010) Chlamydia-specific CD4 T cell clones control Chlamydia muridarum replication in epithelial cells by nitric oxide-dependent and-independent mechanisms. J Immunol 185: 6911-6920.
17. Jayarapu K, Kerr MS, Katschke A, Johnson RM, (2009) Chlamydia muridarum-specific CD4 T-cell clones recognize infected reproductive tract epithelial cells in an interferon-dependent fashion. Infect Immun 77: 4469-4479.
18. Johnson RM, (2004) Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion. Infect Immun 72: 3951-3960.
19. Hawkins RA, Rank RG, Kelly KA, (2002) A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosa. Infect Immun 70: 5132-5139.
20. Yu H, Karunakaran KP, Kelly I, Shen C, Jiang X, et al. (2011) Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells. J Immunol 186: 3615-3621.
21. Kinnunen AH, Surcel HM, Lehtinen M, Karhukorpi J, Tiitinen A, et al. (2002) HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study. Hum Reprod 17: 2073-2078.
22. Asquith KL, Horvat JC, Kaiko GE, Carey AJ, Beagley KW, et al. (2011) Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts. PLoS Pathog 7: e1001339.
23. Johnson RM (2012) Chlamydial Infections. In: Eugene Rosenberg EFD, Fabiano Thompson, Stephen Lory, Erko Stackebrandt editor. The Prokaryotes, 4th Edition. NY: Springer Publishing Co.
24. Morrison SG, Morrison RP, (2001) Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells. Infect Immun 69: 2643-2649.
25. Morrison SG, Morrison RP, (2005) A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J Immunol 175: 7536-7542.
26. Moore T, Ananaba GA, Bolier J, Bowers S, Belay T, et al. (2002) Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology 105: 213-221.
27. Nelson DE, Virok DP, Wood H, Roshick C, Johnson RM, et al. (2005) Chlamydial IFN-{gamma} immune evasion is linked to host infection tropism. Proc Natl Acad Sci U S A 102: 10658-10663.
28. Johnson RM, Yu H, Kerr MS, Slaven JE, Karunakaran KP, et al. (2012) PmpG303-311, a protective vaccine epitope that elicits persistent cellular immune responses in Chlamydia muridarum-immune mice. Infect Immun 80: 2204-2211.
29. Hook CE, Telyatnikova N, Goodall JC, Braud VM, Carmichael AJ, et al. (2004) Effects of Chlamydia trachomatis infection on the expression of natural killer (NK) cell ligands and susceptibility to NK cell lysis. Clin Exp Immunol 138: 54-60.
30. Ibana JA, Aiyar A, Quayle AJ, Schust DJ, (2012) Modulation of MICA on the surface of Chlamydia trachomatis-infected endocervical epithelial cells promotes NK cell-mediated killing. FEMS Immunol Med Microbiol 65: 32-42.
31. Hall RT, Strugnell T, Wu X, Devine DV, Stiver HG, (1993) Characterization of kinetics and target proteins for binding of human complement component C3 to the surface-exposed outer membrane of Chlamydia trachomatis serovar L2. Infect Immun 61: 1829-1834.
32. Lin JS, Yan LL, Ho Y, Rice PA, (1992) Early complement components enhance neutralization of Chlamydia trachomatis infectivity by human sera. Infect Immun 60: 2547-2550.
33. Bode J, Dutow P, Sommer K, Janik K, Glage S, et al. (2012) A New Role of the Complement System: C3 Provides Protection in a Mouse Model of Lung Infection with Intracellular Chlamydia psittaci. PLoS ONE 7: e50327.
34. Williams DM, Schachter J, Weiner MH, Grubbs B, (1984) Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis). Infect Immun 45: 674-678.